BALPHARMA / NSE / Biotechnology & Drugs
Bal Pharma
1Y Price Trend
Key Information
Recommendations
Target High112.97
Target Low59.69
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk45.43
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens MarketsMojo
Enterprise value to revenue forward of Bal Pharma Limited – NSE:BALPHARMA TradingView
Price to book forward of Bal Pharma Limited – NSE:BALPHARMA TradingView
Bal Pharma Ltd is Rated Sell by MarketsMOJO MarketsMojo
Bal Pharma appoints Shreepada ML as Company Secretary scanx.trade
Compare with BAL PHARMA Equitymaster
HEXAGON NUTRITION LTD. Stock/Share price , NSE/BSE Forecast News and Live Quotes Equitymaster
Bal Pharma Ltd Downgraded to Sell Amidst Flat Financials and Weak Fundamentals Markets Mojo
Stock FAQs
What is the symbol and ISIN of Bal Pharma?
Bal Pharma has the symbol BALPHARMA and ISIN - INE083D01012.
What is the current price of Bal Pharma?
Bal Pharma is currently trading at INR 79.46.
What are the year high and year low of Bal Pharma?
Bal Pharma has a year high of INR 112.97 and a year low of INR 59.69.
What is the market capitalization of Bal Pharma?
Bal Pharma has a market capitalization of INR 123.88 crore.
What is the P/E ratio of Bal Pharma?
Bal Pharma has a P/E ratio of 15.26.
What is the dividend yield of Bal Pharma?
Bal Pharma has a dividend yield of 1.54%.
How is the financial performance of Bal Pharma based on revenue, net income, and EPS?
Bal Pharma has revenue of INR 3,116.61 crore, net income of INR 62.84 crore, and EPS of INR 3.96.
What is the book value of Bal Pharma?
Bal Pharma has a book value of INR 40.81.
What is the debt-to-equity ratio of Bal Pharma?
Bal Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Bal Pharma?
Bal Pharma has a price-to-book ratio of 1.95 and a price-to-sales ratio of 0.04.
© SharekeyX | Rusaka Technologies 2024-2026